ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations

ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations

Effects of estrogen receptorβ (ERβ) localization on epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-small cell lung cancer (NSCLC) are unknown. First, we analyzed the relationship between ERβ localization determined by immunohistochemistry and EGFR-TKI outcome...

Full description

Bibliographic Details
Main Authors: Wang, Zhijie, Li, Zhenxiang, Ding, Xiaosheng, Shen, Zhirong, Liu, Zhentao, An, Tongtong, Duan, Jianchun, Zhong, Jia, Wu, Meina, Zhao, Jun, Zhuo, Minglei, Wang, Yuyan, Wang, Shuhang, Sun, Yu, Bai, Hua, Wang, Jie
Format: Online
Language:English
Published: Nature Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476037/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476037/

Similar Items